Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 785 results for "tyrosine"

AB Science: Web conference on masitinib in asthma - Safety and Efficacy Update

Brutons Tyrosine Kinase (Btk) Inhibitors -Pipeline Insights, 2014

SUMMARY DelveInsight's,Brutons Tyrosine Kinase (Btk) Inhibitors-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the ..., 11 hours ago

24 images for tyrosine

Springer Link Journal, 1 day ago
Pharmaceutical Journal, 2 days ago
MDLinx, 4 days ago
MDLinx, 4 days ago
MDLinx, 4 days ago
MDLinx, 4 days ago
MDLinx, 4 days ago
MDLinx, 4 days ago
MDLinx, 4 days ago
MDLinx, 4 days ago

Chaetocin synergistic with TKIs against CML cells

medwireNews: Chaetocin, a mycotoxin that increases oxidative stress, can complement the activity of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukaemia (CML) by overcoming innate resistance mediated by secreted bone marrow stromal ...
 MedWire News2 weeks ago
Med India

New Drug To Reduce Side Effects Of Modern Cancer Treatment

A new strategy to reduce the serious side effects of an important class of modern anticancer drugs (tyrosine kinase inhibitors) has been established jointly by an interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic ...
 Med India1 month ago
Med India

Continuing Tyrosine Kinase Inhibitor Therapy After Resistance Development in Lung Cancer

A phase III trial has shown that patients whose lung cancer has developed resistance to the drug gefitinib experience no statistically significant improvement in progression-free survival from continued treatment with the drug in addition to chemotherapy. The ...
 Med India1 month ago Treatment-resistant advanced non-small cell lung cancer responds to rociletinib  Science Daily1 day ago New drug shows promise against treatment-resistant non-small cell lung cancer  News-Medical.Net5 days ago Trial results show treatment-resistant advanced non-small cell lung cancer responds to new drug, rociletinib  European Cancer Organisation1 week ago
Springer Link Journal

Receptor Tyrosine Kinases: Structure, Functions and Role in Human Disease

2015 ISBN: 978-1-4939-2052-5 (Print) 978-1-4939-2053-2 (Online)
 Springer Link Journal1 day ago

Structure-Based Network Analysis of Activation Mechanisms in the ErbB Family of Receptor Tyrosine Kinases: The Regulatory Spine Residues Are Global Mediators of Structural Stability and Allosteric Interactions

Sorry, the article that you've requested cannot be found; please check the Digital Object Identifier (DOI) and try again. Please use the advanced search form to locate an article. If you continue to experience problems with the ...
 Plosone.org1 day ago

Reports Summarize Receptor Protein-Tyrosine Kinases Findings from AstraZeneca [Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both...

Reports Summarize Receptor Protein-Tyrosine Kinases Findings from AstraZeneca [Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor] By a ...
 4 Traders2 days ago New Cardiomyopathies Findings from Columbia University Reported (Mitogen-activated protein kinase kinase 1/2 inhibition and angiotensin II converting...  4 Traders1 week ago

Increased Frequency of a Unique Spleen Tyrosine Kinase Bright Memory B Cell Population in Systemic Lupus Erythematosus

Objective Systemic lupus erythematosus (SLE) is characterized by B cell hyperactivity and autoantibody production. As spleen tyrosine kinase (Syk) is pivotal in B cell activation, these experiments aimed to examine the extent to which Syk was ...
 Arthritis & Rheumatism2 days ago

Probing the target-specific inhibition of sensitized protein tyrosine phosphatases with biarsenical probes

We welcome your comments for improvement of this site and our services. Comments Email ID Security Details ...
 RSC3 days ago

No survival benefit with dacomitinib in pretreated patients with advanced NSCLC

By Lucy Piper, Senior medwireNews Reporter The irreversible, pan-epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) dacomitinib does not offer a survival benefit in pretreated patients with advanced or metastatic ...
 News-Medical.Net1 week ago Dacomitinib not superior to erlotinib in advanced NSCLC  MedWire News4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less